Curate Biosciences

Chief Executive Officer

Mike is a serial entrepreneur dedicated to positively impacting human health, who has built six venture-backed life science and healthcare companies with significant returns to investors including Paradigm Corporation and Verinata Health, Inc.  He has spent the last five years focused on addressing critical gaps that have stymied cell and gene therapy advancements, leveraging Curate Biosciences’ microfluidics technology to help expand access and improve patient outcomes. Mike is a graduate of UC Berkeley and the Stanford Graduate School of Business. 

Chief Technology Officer

Tony previously served as the global strategic marketing director for Becton Dickinson’s research cell analysis business as well as headed commercial operations for eBioscience from startup through sale to Affymetrix, where he served as SVP/general manager for the business unit. Tony’s background also includes developing and commercializing multiple flow cytometry and assay product technologies. He received his BS in Microbiology from California Polytechnic State University and his MBA from Santa Clara University.

Chief Financial Officer

Before joining GPB to lead business development and then finance, Jason served as director of strategic growth for Corning Life Sciences and Corning’s emerging innovations group and as VP & general manager of Corning’s cell culture media and reagents business upon its acquisition. His background also includes other general management and strategy/M&A leadership roles at Corning and Quest Diagnostics and serving clients in McKinsey & Co.’s Pharmaceutical and Medical Products practice. He earned his BA from St. John’s College in Annapolis, Maryland and his MBA from Harvard Business School.

Chief Business Officer

Prior to joining GPB, Gaurav served as Head of BD for Precigen Inc. His background also includes key business development roles at Gilead Sciences, Shire Pharmaceuticals and Amgen, where he led various transactions across therapeutic areas (mostly oncology) and helped build large-pharma pipeline via sourcing external innovation. He earned his MBA from University of Michigan and his MS from Wayne State University, Michigan.

Senior Vice President, Manufacturing and Supply Chain

Before joining GPB, Joan served as Site Director for Millipore Sigma Viral Vector Manufacturing. Prior to Millipore-Sigma she has served in senior Operations leadership positions for leading diagnostic companies, including Vice President of Manufacturing & Technical Operations for GenMark Diagnostics and Executive Director of Technical Operations for Cepheid. She has more than 20 years of Operations, R&D and Project Management leadership experience in both commercial and early stage therapeutic and diagnostic applications. Joan holds a PhD in Neuroscience from the University of Oregon and a BS in Cellular & Molecular Biology from San Francisco State University.

Vice President, Product Development and Manufacturing

Khushroo’s background includes serving as site manager and director of chip process development and manufacturing for Caliper LifeSciences (now a Perkin Elmer company) and R&D director at Pilkington Barnes-Hind. He has scaled up and transferred into manufacturing multiple microfluidic chip and reagents product lines. Khushroo received his BTech degree in Chemical Engineering from the India Institute of Technology, his MS in Chemical Engineering and his PhD in Polymer Science and Engineering from USC.

Vice President, Biology

Roberto’s prior positions include director of antibody products and assay development at Cell Signaling Technology. He served as director at R&D systems (Bio-Techne) and director of cell signaling research at BD Biosciences, and co-founded Transduction Laboratories. He earned his BS Biology from Universidad Autónoma de Guadalajara, his MSc Biology and his PhD in Biology from the University of Ottawa with post-doctoral fellowships in Cancer Research at University of Hawaii and University of Kentucky.

Senior Director, Engineering and IP Strategy

Alison previously was a senior scientist and held various advisor/consultant positions at Verily Life Sciences, Cannon, On-Q-ity and T2 Biosystems. She has more than 20 years of experience in all aspects of microfluidic devices including design, fabrication and evaluation. Alison received her BSc. (Honors) in Chemistry from the University of Alberta and her PhD in Chemistry from the UC Berkeley, with post-doctoral work in Bioengineering at MIT.

Director of Finance and Administration

Before joining GPB, Deepa held the position of Director of Finance at Westfield where she led the regional Finance team in all areas of Accounting, Finance, Development and Management. Her background also includes holding finance and accounting leadership roles at Eclipse Bioinnovations, IWS Systems and OAG Consultants. Deepa received her BBA in Accounting from University of Manitoba in Canada.

Marketing Manager

Cole previously served as Product Manager at 10x Genomics and Miltenyi Biotec where he developed strategic corporate partnerships and collaborations to drive new business within new markets. His background also includes tissue regeneration research at Brigham and Women’s Hospital, viral vector vaccine development at Novartis, and antibody-based therapies at Kyowa Kirin Pharma. Cole received his BS in Chemistry at Emory University. 

Senior Microfluidics Engineer

Yasna has been a team member at GPB Scientific since 2018, utilizing her knowledge of microfluidics during the design and development of the Curate Cell Processing System. She collaborates cross-functionally to conceive and assess new concepts while evaluating GPB’s DCS technology. Yasna earned her BS in Biomedical Engineering from UC Irvine and her MS in Bioengineering from San Diego State University.

Quality Engineer

Prior to GPB, Rechea worked as a Quality Engineering team lead at Applied Medical. Utilizing her exposure to mechanical and electrical device failure analyses, Rechea strives to obtain continuous quality improvements for the Curate system. She has earned her BS in Biological Engineering and M.Eng in Biomedical Engineering from Cornell University.